Positions

Overview

  • Dr. Mugavero joined the ID faculty at UAB in 2006 and was named Project Director of the UAB 1917 Clinic Cohort a prospective, observational HIV cohort study. His research focuses on the effects of clinical, behavioral and epidemiological factors on health behaviors and outcomes in HIV patients. Dr. Mugavero serves as Associate Director for the Center for Outcomes Effectiveness Research and Education, Co-Director of the Center For AIDS Research, and Director of its Clinical Core facility.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation.Clinical Infectious Diseases.  68:475-481. 2019
    2019 Resilience and HIV: a review of the definition and study of resilience.AIDS Care.  1-12. 2019
    2018 Circumstances Surrounding High-risk Sexual Experiences Among Primary Care Patients Living With and Without HIV.Journal of General Internal Medicine.  33:2163-2170. 2018
    2018 Perceptions of HIV Pre-Exposure Prophylaxis among Young, Black Men Who Have Sex with MenAIDS patient care.  32:511-518. 2018
    2018 Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates.Annals of Epidemiology2018
    2018 Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.AIDS Research and Human Retroviruses.  34:916-921. 2018
    2018 PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States.Journal of the Association of Nurses in AIDS Care.  29:835-848. 2018
    2018 HIV Standard of Care for ART Adherence and Retention in Care Among HIV Medical Care Providers Across Four CNICS Clinics in the US.AIDS and Behavior2018
    2018 HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence.AIDS and Behavior2018
    2018 Development and content validation of measures assessing adherence barriers and behaviors for use in clinical care.Research in Social and Administrative Pharmacy2018
    2018 Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration.Journal of Clinical Medicine.  7. 2018
    2018 Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care.Journal of General Internal Medicine.  33:1661-1668. 2018
    2018 Generalizing evidence from randomized trials using inverse probability of sampling weightsJournal of the Royal Statistical Society: Series A.  181:1193-1209. 2018
    2018 Trajectories of Depressive Symptoms Among a Population of HIV-Infected Men and Women in Routine HIV Care in the United States.AIDS and Behavior.  22:3176-3187. 2018
    2018 Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?AIDS and Behavior2018
    2018 Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.Epidemiology.  30:69-74. 2018
    2018 Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort.AIDS.  32:2217-2225. 2018
    2018 HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.Annals of Internal Medicine.  169:376-384. 2018
    2018 Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.Journal of Acquired Immune Deficiency Syndromes.  79:77-82. 2018
    2018 Viremia copy-years and mortality among cART-initiating HIV-positive individuals: how much viral load history is enough?AIDS2018
    2018 Suboptimal Retention in Care Among Recently Released Prisoners: Implications for Social Workers in HIV Primary Care.AIDS and Behavior2018
    2018 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.Journal of the American Medical Association.  320:379-396. 2018
    2018 Who Will Show? Predicting Missed Visits Among Patients in Routine HIV Primary Care in the United States.AIDS and Behavior2018
    2018 Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.Journal of Clinical Lipidology.  12:988-998.e5. 2018
    2018 Stigma Reduction Among African American Women With HIV: UNITY Health Study.Journal of Acquired Immune Deficiency Syndromes.  78:269-275. 2018
    2018 The Ryan White HIV/AIDS Program: Supplementary Service Provision Post-Affordable Care Act.AIDS patient care.  32:265-271. 2018
    2018 The State of Adherence to HIV Care in Black Women.Journal of the Association of Nurses in AIDS Care.  29:487-503. 2018
    2018 Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial.Controlled Clinical Trials.  69:48-54. 2018
    2018 Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.Infectious Disease Clinics of North America.  32:407-423. 2018
    2018 Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States.Clinical Infectious Diseases.  66:1230-1238. 2018
    2018 Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States.JAMA Psychiatry.  75:379-385. 2018
    2018 Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV.Alcoholism: Clinical and Experimental Research.  42:561-570. 2018
    2018 Advantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice.Journal of General Internal Medicine.  33:207-215. 2018
    2018 Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework.American Journal of Epidemiology.  187:316-325. 2018
    2018 Reply.Journal of Acquired Immune Deficiency Syndromes.  77:e22. 2018
    2018 Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence.Journal of General Internal Medicine.  33:136-138. 2018
    2018 Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure.AIDS.  32:347-355. 2018
    2018 Mental health service utilization is associated with retention in care among persons living with HIV at a university-affiliated HIV clinic.AIDS Research and Therapy.  15:1. 2018
    2018 Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens.AIDS.  32:261-266. 2018
    2018 Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.Antiviral Therapy.  23:363-372. 2018
    2018 Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States.PLoS ONE.  13:e0194940. 2018
    2017 Implications of DRG Classification in a Bundled Payment Initiative for COPD.Am J Accountable Care.  5:12-18. 2017
    2017 Characterising HIV transmission risk among US patients with HIV in care: a cross-sectional study of sexual risk behaviour among individuals with viral load above 1500 copies/mL.Sexually Transmitted Infections.  94:206-211. 2017
    2017 Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model.Biometrical Journal.  60:100-114. 2017
    2017 Association Between Internalized HIV-Related Stigma and HIV Care Visit Adherence.Journal of Acquired Immune Deficiency Syndromes.  76:482-487. 2017
    2017 Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.Clinical Infectious Diseases.  65:636-643. 2017
    2017 Response to Letter from Clement et al. Commenting on "The Right People, Right Places, and Right Practices: Disparities in PrEP Access Among African American Men, Women and MSM in the Deep South".Journal of Acquired Immune Deficiency Syndromes2017
    2017 Moment-to-moment within-person associations between acts of discrimination and internalized stigma in people living with HIV: An experience sampling study.Stigma and Health.  2:216-228. 2017
    2017 The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care.Journal of Acquired Immune Deficiency Syndromes.  76:402-408. 2017
    2017 A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.AIDS and Behavior.  21:1975-1984. 2017
    2017 Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.AIDS and Behavior.  21:1914-1925. 2017
    2017 Race and sex differences in ambulatory blood pressure measures among HIV+ adults.Journal of the American Society of Hypertension.  11:420-427.e3. 2017
    2017 The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.AIDS and Behavior.  21:1878-1884. 2017
    2017 HIV Care Initiation Delay Among Rural Residents in the Southeastern United States, 1996 to 2012.Journal of Acquired Immune Deficiency Syndromes.  76:171-176. 2017
    2017 A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention Trials: Development, Key Software Features, and Results of a User Survey.JMIR Research Protocols.  6:e115. 2017
    2017 Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.Clinical Infectious Diseases.  64:1791-1794. 2017
    2017 Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.AIDS and Behavior.  22:742-751. 2017
    2017 Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.Clinical Infectious Diseases.  64:1591-1596. 2017
    2017 Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.Lancet HIV.  4:e251-e259. 2017
    2017 Validity assessment of the PROMIS fatigue domain among people living with HIV.AIDS Research and Therapy.  14:21. 2017
    2017 Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.AIDS and Behavior.  21:1138-1148. 2017
    2017 Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.JAMA Cardiology.  2:260-267. 2017
    2017 Relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.AIDS.  31:1009-1016. 2017
    2017 Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.AIDS Research and Human Retroviruses2017
    2017 A Comparison of Adherence Timeframes Using Missed Dose Items and Their Associations with Viral Load in Routine Clinical Care: Is Longer Better?AIDS and Behavior.  21:470-480. 2017
    2017 Brief Report: Interpersonal and Intrapersonal Factors as Parallel Independent Mediators in the Association Between Internalized HIV Stigma and ART Adherence.Journal of Acquired Immune Deficiency Syndromes.  74:e18-e22. 2017
    2017 Brief Report: The Right People, Right Places, and Right Practices: Disparities in PrEP Access Among African American Men, Women, and MSM in the Deep South.Journal of Acquired Immune Deficiency Syndromes.  74:56-59. 2017
    2017 How Does Stigma Affect People Living with HIV? The Mediating Roles of Internalized and Anticipated HIV Stigma in the Effects of Perceived Community Stigma on Health and Psychosocial Outcomes.AIDS and Behavior.  21:283-291. 2017
    2017 Interpersonal Mechanisms Contributing to the Association Between HIV-Related Internalized Stigma and Medication Adherence.AIDS and Behavior.  21:238-247. 2017
    2017 Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence.Research in Social and Administrative Pharmacy.  14:540-544. 2017
    2017 Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort.PLoS ONE.  12:e0166435. 2017
    2017 Patient preferences for antiretroviral therapy: effectiveness, quality of life, access and novel delivery methods.Patient Preference and Adherence.  11:1585-1590. 2017
    2017 Validity assessment of the PROMIS fatigue domain among people living with HIV.AIDS Research and Therapy.  14:21. 2017
    2016 Identifying HIV care enrollees at-risk for cannabis use disorder.AIDS Care.  29:846-850. 2016
    2016 Co-calibration of two self-reported measures of adherence to antiretroviral therapy.AIDS Care.  29:464-468. 2016
    2016 Heavy Alcohol Use Is Associated With Worse Retention in HIV Care.Journal of Acquired Immune Deficiency Syndromes.  73:419-425. 2016
    2016 Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.Journal of Acquired Immune Deficiency Syndromes.  73:482-488. 2016
    2016 A Qualitative Study on Health Numeracy and Patient-Provider Communication of Laboratory Numbers in Older African Americans with HIV.Journal of the Association of Nurses in AIDS Care.  27:826-834. 2016
    2016 Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department.Open Forum Infectious Diseases.  3:ofw211. 2016
    2016 Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders.AIDS Care.  29:177-184. 2016
    2016 Editorial Commentary: Affordable Care Act, Medicaid Expansion … or Not: Ryan White Care Act Remains Essential for Access and Equity.Clinical Infectious Diseases.  63:404-406. 2016
    2016 An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects.American Journal of Epidemiology.  184:336-344. 2016
    2016 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.Journal of the American Medical Association.  316:191-210. 2016
    2016 Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.Journal of the American Medical Association.  316:156-170. 2016
    2016 Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.Clinical Infectious Diseases.  63:976-983. 2016
    2016 When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.Journal of Acquired Immune Deficiency Syndromes.  72:214-221. 2016
    2016 Provider perceptions of the value of same-day, electronic patient-reported measures for use in clinical HIV care.AIDS Care.  28:1428-1433. 2016
    2016 Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting.Drug and Alcohol Dependence.  164:113-119. 2016
    2016 Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications.Journal of Acquired Immune Deficiency Syndromes.  73:205-212. 2016
    2016 Social support and moment-to-moment changes in treatment self-efficacy in men living with HIV: Psychosocial moderators and clinical outcomes.Health Psychology.  35:1126-1134. 2016
    2016 Cost considerations in the current antiretroviral era.AIDS.  30:2115-2119. 2016
    2016 Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research.Open Forum Infectious Diseases.  3:ofw109. 2016
    2016 Reported Church Attendance at the Time of Entry into HIV Care is Associated with Viral Load Suppression at 12 Months.AIDS and Behavior.  20:1706-1712. 2016
    2016 Content validity of Patient-Reported Outcomes Measurement Information System (PROMIS) items in the context of HIV clinical care.Quality of Life Research.  25:293-302. 2016
    2016 The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.International Journal of Epidemiology.  45:140-150. 2016
    2016 Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis.PLoS ONE.  11:e0148920. 2016
    2016 Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics.Journal of Addiction Medicine.  10:13-19. 2016
    2016 Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United States.PLoS ONE.  11:e0160738. 2016
    2016 Geographic Variations in Retention in Care among HIV-Infected Adults in the United States.PLoS ONE.  11:e0146119. 2016
    2016 Predictors of HIV Disclosure in Infected Persons Presenting to Establish Care.AIDS and Behavior.  20:147-154. 2016
    2016 The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future.AIDS Research and Therapy.  13:35. 2016
    2015 Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.International Journal of Epidemiology.  45:2038-2049. 2015
    2015 Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization.American Journal of Epidemiology.  182:1039-1046. 2015
    2015 Immunization costs and programmatic barriers at an urban HIV clinic.Clinical Infectious Diseases.  61:1726-1731. 2015
    2015 The Role of Early HIV Status Disclosure in Retention in HIV Care.AIDS patient care.  29:646-650. 2015
    2015 Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States.Clinical Infectious Diseases.  61:1189-1195. 2015
    2015 The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.American Journal of Public Health.  105:2068-2075. 2015
    2015 The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.AIDS.  29:1975-1986. 2015
    2015 Achieving Core Indicators for HIV Clinical Care Among New Patients at an Urban HIV Clinic.AIDS patient care.  29:474-480. 2015
    2015 Multiple Imputation to Account for Measurement Error in Marginal Structural Models.Epidemiology.  26:645-652. 2015
    2015 Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults.AIDS Research and Human Retroviruses.  31:898-904. 2015
    2015 Factors Associated with Missed Psychiatry Visits in an Urban HIV ClinicAIDS and Behavior.  19:1423-1429. 2015
    2015 Factors Associated with Missed Psychiatry Visits in an Urban HIV Clinic.AIDS and Behavior.  19:1423-1429. 2015
    2015 Dynamic Visual Display of Treatment Response in HIV-Infected Adults.Clinical Infectious Diseases.  61:e1-e4. 2015
    2015 Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.Clinical Infectious Diseases.  60:1700-1707. 2015
    2015 Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS.AIDS Research and Human Retroviruses.  31:519-524. 2015
    2015 Improving parental stress levels among mothers living with HIV: a randomized control group intervention study.AIDS patient care.  29:220-228. 2015
    2015 End-stage renal disease among HIV-infected adults in North America.Clinical Infectious Diseases.  60:941-949. 2015
    2015 Estimating the cost of increasing retention in care for HIV-infected patients: results of the CDC/HRSA retention in care trial.Journal of Acquired Immune Deficiency Syndromes.  68:345-350. 2015
    2015 Self-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral Load.Journal of the International Association of Providers of AIDS Care.  14:156-162. 2015
    2015 Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy.American Journal of Epidemiology.  181:238-245. 2015
    2015 Adherence to Appointments for Comprehensive Primary Care of HIV Patients With Substance Use DisordersJournal of HIV/AIDS and Social Services.  14:45-57. 2015
    2015 Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels.AIDS Research and Treatment.  2015:478750. 2015
    2015 Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.Antiviral Therapy.  20:21-28. 2015
    2015 The multiple stigma experience and quality of life in older gay men with HIV.Journal of the Association of Nurses in AIDS Care.  26:24-35. 2015
    2014 Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.Clinical Infectious Diseases.  59:1471-1479. 2014
    2014 Connecting the dots: could microbial translocation explain commonly reported symptoms in HIV disease?Journal of the Association of Nurses in AIDS Care.  25:483-495. 2014
    2014 A qualitative study of underutilization of the AIDS drug assistance program.Journal of the Association of Nurses in AIDS Care.  25:392-404. 2014
    2014 Bone alterations associated with HIV.Current HIV/AIDS Reports.  11:233-240. 2014
    2014 Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence.Infectious Disease Clinics of North America.  28:355-369. 2014
    2014 Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics.Clinical Infectious Diseases.  59:725-734. 2014
    2014 The authors reply.American Journal of Epidemiology.  180:450. 2014
    2014 Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.Clinical Infectious Diseases.  59:287-297. 2014
    2014 Reply to Rapose.Clinical Infectious Diseases.  59:316-317. 2014
    2014 Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.Clinical Infectious Diseases.  59 Suppl 1:S21-S27. 2014
    2014 African American race and HIV virological suppression: beyond disparities in clinic attendance.American Journal of Epidemiology.  179:1484-1492. 2014
    2014 HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.Clinical Infectious Diseases.  58:1599-1606. 2014
    2014 Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort.Journal of Acquired Immune Deficiency Syndromes.  66:96-101. 2014
    2014 Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.Clinical Infectious Diseases.  58:1297-1307. 2014
    2014 Social Determinants of Late Presentation to HIV CareJournal of health disparities research and practice.  7:37-47. 2014
    2014 Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.AIDS.  28:979-987. 2014
    2014 Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.American Journal of Epidemiology.  179:996-1005. 2014
    2014 Disparities in the quality of HIV care when using US Department of Health and Human Services indicators.Clinical Infectious Diseases.  58:1185-1189. 2014
    2014 A conceptual framework for understanding chronic pain in patients with HIV.Pain Practice.  14:207-216. 2014
    2014 Low back pain and associated imaging findings among HIV-infected patients referred to an HIV/palliative care clinic.Pain Medicine.  15:418-424. 2014
    2014 The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans.AIDS Research and Human Retroviruses.  30:233-240. 2014
    2014 Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.Virology.  449:254-262. 2014
    2014 Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.Journal of the International AIDS Society.  17:19045. 2014
    2014 Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care.Clinical Infectious Diseases.  58:295-299. 2014
    2014 Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators.PLoS ONE.  9:e102305. 2014
    2014 The authors reply.American Journal of Epidemiology.  180:450. 2014
    2013 Pain is independently associated with impaired physical function in HIV-infected patients.Pain Medicine.  14:1985-1993. 2013
    2013 Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.Journal of Acquired Immune Deficiency Syndromes.  64:254-260. 2013
    2013 Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapyBMJ Open.  3:927-935. 2013
    2013 Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.Journal of Infectious Diseases.  208:1240-1249. 2013
    2013 A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV.Addictive Behaviors.  38:2541-2546. 2013
    2013 A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011.Clinical Infectious Diseases.  57:1027-1037. 2013
    2013 Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment.AIDS and Behavior.  17:2781-2791. 2013
    2013 The state of engagement in HIV care in the United States: from cascade to continuum to control.Clinical Infectious Diseases.  57:1164-1171. 2013
    2013 Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.Clinical Infectious Diseases.  57:756-764. 2013
    2013 Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Milbank Quarterly.  91:558-603. 2013
    2013 Characteristics of an ambulatory palliative care clinic for HIV-infected patients.Journal of Palliative Medicine.  16:934-937. 2013
    2013 Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States.AIDS patient care.  27:442-449. 2013
    2013 The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression.AIDS patient care.  27:459-466. 2013
    2013 High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.Journal of Acquired Immune Deficiency Syndromes.  63:299-306. 2013
    2013 Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States.Clinical Infectious Diseases.  56:1800-1809. 2013
    2013 Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomes.AIDS Research and Human Retroviruses.  29:698-703. 2013
    2013 Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.AIDS.  27:803-813. 2013
    2013 Erratum: Migrating from a legacy fixed-format measure to CAT administration: Calibrating the PHQ-9 to the PROMIS depression measures (Quality of Life Research (2011) 20 (1349-1357) DOI 10.1007/s11136-011-9882-y)Quality of Life Research.  22:459-460. 2013
    2013 Retention among North American HIV-infected persons in clinical care, 2000-2008.Journal of Acquired Immune Deficiency Syndromes.  62:356-362. 2013
    2013 Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV.AIDS and Behavior.  17:307-318. 2013
    2013 HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy.PLoS ONE.  8:e84318. 2013
    2013 Late diagnosis, delayed presentation and late presentation in HIV: proposed definitions, methodological considerations and health implications.Antiviral Therapy.  18:17-23. 2013
    2013 Maraviroc observational study: the impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced patients.AIDS Research and Human Retroviruses.  29:105-111. 2013
    2013 Support, stigma, health, coping, and quality of life in older gay men with HIV.Journal of the Association of Nurses in AIDS Care.  24:38-49. 2013
    2012 Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering.Journal of Acquired Immune Deficiency Syndromes.  61:600-605. 2012
    2012 Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.Clinical Infectious Diseases.  55:1550-1557. 2012
    2012 Coping with HIV stigma: do proactive coping and spiritual peace buffer the effect of stigma on depression?AIDS and Behavior.  16:2382-2391. 2012
    2012 A low-effort, clinic-wide intervention improves attendance for HIV primary care.Clinical Infectious Diseases.  55:1124-1134. 2012
    2012 Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure.Journal of Acquired Immune Deficiency Syndromes.  61:164-170. 2012
    2012 U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.Annals of Internal Medicine.  157:325-335. 2012
    2012 Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.Controlled Clinical Trials.  33:828-838. 2012
    2012 Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.Annals of Internal Medicine.  156:817-294. 2012
    2012 Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways.Journal of Acquired Immune Deficiency Syndromes.  59:409-416. 2012
    2012 Short communication routine HIV testing in the emergency department: assessment of patient perceptions.AIDS Research and Human Retroviruses.  28:352-356. 2012
    2012 Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States.PLoS ONE.  7:e31591. 2012
    2012 Breaking the silence: the insidious effects of trauma and PTSD.Positively aware : the monthly journal of the Test Positive Aware Network.  24:15-17. 2012
    2012 Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.Journal of Acquired Immune Deficiency Syndromes.  59:86-93. 2012
    2012 HIV infection and obesity: where did all the wasting go?Antiviral Therapy.  17:1281-1289. 2012
    2012 HIV-infected women's relationships with their health care providers in the rural deep south: an exploratory study.Health Care for Women International.  33:403-419. 2012
    2012 Patient reported outcomes in routine care: advancing data capture for HIV cohort research.Clinical Infectious Diseases.  54:141-147. 2012
    2011 The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?Clinical Infectious Diseases.  53:1168-1169. 2011
    2011 Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.Journal of Acquired Immune Deficiency Syndromes.  58:253-260. 2011
    2011 Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures.Quality of Life Research.  20:1349-1357. 2011
    2011 Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.Clinical Infectious Diseases.  53:927-935. 2011
    2011 The role of toxicity-related regimen changes in the development of antiretroviral resistance.AIDS Research and Human Retroviruses.  27:957-963. 2011
    2011 Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality.Journal of General Internal Medicine.  26:745-750. 2011
    2011 Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.Health Services Research.  46:982-995. 2011
    2011 Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.AIDS.  25:691-700. 2011
    2011 Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.Clinical Infectious Diseases.  52:387-395. 2011
    2011 Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep South.AIDS Care.  23:152-162. 2011
    2011 Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system.Clinical Infectious Diseases.  52 Suppl 2:S238-S246. 2011
    2011 Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.AIDS.  25:185-195. 2011
    2011 Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life.Journal of the Association of Nurses in AIDS Care.  22:17-25. 2011
    2011 Navigating the maze. Strategies for successful partnerships in HIV care.Positively aware : the monthly journal of the Test Positive Aware Network.  23:4-6. 2011
    2011 Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.Patient Preference and Adherence.  5:357-367. 2011
    2010 Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks.AIDS Research and Human Retroviruses.  26:1279-1285. 2010
    2010 Perceived barriers to HIV care among HIV-infected women in the Deep South.Journal of the Association of Nurses in AIDS Care.  21:467-477. 2010
    2010 From access to engagement: measuring retention in outpatient HIV clinical care.AIDS patient care.  24:607-613. 2010
    2010 Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.Clinical Infectious Diseases.  51:718-724. 2010
    2010 Incident stressful and traumatic life events and human immunodeficiency virus sexual transmission risk behaviors in a longitudinal, multisite cohort study.Psychosomatic Medicine.  72:720-726. 2010
    2010 A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions.AIDS patient care.  24:515-520. 2010
    2010 Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.Journal of Acquired Immune Deficiency Syndromes.  54:442-444. 2010
    2010 Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.HIV Medicine.  11:462-468. 2010
    2010 Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9).AIDS Care.  22:874-885. 2010
    2010 Bone changes and fracture risk in individuals infected with HIV.Current Rheumatology Reports.  12:163-169. 2010
    2010 Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.Clinical Infectious Diseases.  50:1387-1396. 2010
    2010 Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting.Clinical Infectious Diseases.  50:1165-1173. 2010
    2010 Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care.Clinical Infectious Diseases.  50:574-584. 2010
    2010 Antiretroviral prescribing patterns in treatment-naïve patients in the United States.AIDS patient care.  24:79-85. 2010
    2010 Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing.Journal of Acquired Immune Deficiency Syndromes.  53:215-221. 2010
    2010 Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.American Journal of Epidemiology.  171:198-205. 2010
    2010 New syphilis cases and concurrent STI screening in a southeastern U.S. HIV clinic: a call to action.AIDS patient care.  24:23-29. 2010
    2009 Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.Journal of Acquired Immune Deficiency Syndromes.  52:357-363. 2009
    2009 Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study.Psychosomatic Medicine.  71:920-926. 2009
    2009 Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study.AIDS.  23:1539-1546. 2009
    2009 Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.Clinical Infectious Diseases.  48:1138-1151. 2009
    2009 Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.Clinical Infectious Diseases.  48:787-794. 2009
    2009 Missed visits and mortality among patients establishing initial outpatient HIV treatment.Clinical Infectious Diseases.  48:248-256. 2009
    2009 Racial disparities in HIV virologic failure: do missed visits matter?Journal of Acquired Immune Deficiency Syndromes.  50:100-108. 2009
    2009 The therapeutic implications of timely linkage and early retention in HIV care.AIDS patient care.  23:41-49. 2009
    2008 Improving engagement in HIV care: what can we do?Topics in HIV Medicine.  16:156-161. 2008
    2008 Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?AIDS.  22:2481-2492. 2008
    2008 Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast.AIDS patient care.  22:869-877. 2008
    2008 Short-term discontinuation of HAART regimens more common in vulnerable patient populations.AIDS Research and Human Retroviruses.  24:1347-1355. 2008
    2008 Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.AIDS.  22:1951-1960. 2008
    2008 Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic.Clinical Infectious Diseases.  46:1315-1318. 2008
    2008 Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.Journal of Acquired Immune Deficiency Syndromes.  47:553-558. 2008
    2008 The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.Journal of Acquired Immune Deficiency Syndromes.  47:194-201. 2008
    2007 Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.Southern Medical Journal.  100:1114-1122. 2007
    2007 Relation of lifetime trauma and depressive symptoms to mortality in HIV.American Journal of Psychiatry.  164:1707-1713. 2007
    2007 Childhood abuse and initial presentation for HIV care: an opportunity for early intervention.AIDS Care.  19:1083-1087. 2007
    2007 Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era.Clinical Infectious Diseases.  45:658-661. 2007
    2007 Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.AIDS patient care.  21:681-690. 2007
    2007 Failure to establish HIV care: characterizing the "no show" phenomenon.Clinical Infectious Diseases.  45:127-130. 2007
    2007 Late diagnosis of HIV infection: the role of age and sex.American Journal of Medicine.  120:370-373. 2007
    2007 HIV care at a crossroads: the emerging crisis in the US HIV epidemic.MedGenMed : Medscape general medicine.  9:58. 2007
    2006 Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events.AIDS patient care.  20:418-428. 2006
    2006 Distribution of health care expenditures for HIV-infected patients.Clinical Infectious Diseases.  42:1003-1010. 2006
    2004 HIV resistance and the effectiveness of combination antiretroviral treatmentDrug Discovery Today: Therapeutic Strategies.  1:529-535. 2004
    2003 Duration of highly active antiretroviral therapy regimens.Clinical Infectious Diseases.  37:714-722. 2003
    Elements of the HIV Care Continuum: Improving Engagement and Retention in Care.Topics in antiviral medicine.  24:115-119.

    Principal Investigator On

  • Evaluation of the Efficacy and Mechanisms of a Novel Intervention for Chronic Pain Tailored to People Living with HIV  awarded by University of Pittsburgh 2018 - 2023
  • 3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)  awarded by UNIVERSITY OF WASHINGTON 2016 - 2021
  • Pathways Contributing to Racial Disparities in HIV Virologic Response  awarded by Brown University 2016 - 2021
  • A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM  awarded by Columbia University 2016 - 2021
  • Multi-Level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits  awarded by VANDERBILT UNIVERSITY 2018 - 2019
  • HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex with Men (MSM) in the United States  awarded by FAMILY HEALTH INTERNATIONAL 2015 - 2019
  • AIDS Education and Training Centers Program  awarded by VANDERBILT UNIVERSITY 2015 - 2019
  • The Role of Resilience in Addressing Racial Disparities in Adverse HIV-Related Outcomes  awarded by Brown University 2017 - 2019
  • UAB Center for AIDS Research - Clinical Core C  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Data 4 CARE Alabama: Clinics Achieving Retention & Engagement by Implementing CDC EBis via the Alabama Regional Quality Group  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2018 - 2019
  • Seek, Test, Treat, and Retain Data Harmonization Coordinating Center  awarded by UNIVERSITY OF WASHINGTON 2014 - 2019
  • Game Changer  awarded by AIDS ALABAMA 2015 - 2018
  • Development and Validation of a Multidimensional Index of Engagement in HIV Care  awarded by University of California, San Francisco 2013 - 2018
  • Integrating ENGagement and Adherence Goals upon Entry iENGAGE to Control HIV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2012 - 2018
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2017
  • The Causal Effect of Effective Depression Treatment on HIV Outcomes in CNICS  awarded by University of North Carolina at Chapel Hill 2013 - 2017
  • Reducing Stigma to Improve Health Outcomes for African-American Women  awarded by University of Washington, Seattle 2012 - 2017
  • Southern Consortium Node of The Clinical Trials Network: CTN-0064  awarded by Medical University of South Carolina 2015 - 2017
  • Implementation and Evaluation of a Comprehensive Prevention with Positives Intervention at HIV Clinics  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2011 - 2016
  • ARCH-ERA Alcohol Research Consortium in HIV-Epidemiological Research Arm  awarded by University of Washington, Seattle 2011 - 2016
  • A Statistical Framework for Integrated Analysis of the US HIV Care Cascade Using Data From CNICS  awarded by THE MIRIAM HOSPITAL 2015 - 2016
  • Living Well Retention in Care Program  awarded by AIDS ALABAMA 2013 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2015
  • The Southern Consortium Node of the Clinical Trials Network  awarded by Medical University of South Carolina 2012 - 2015
  • Improving HAART Adherence in Depressed HIV Clinic Patients: A Real World RCT  awarded by Duke University 2011 - 2014
  • UAB Center for AIDS Research - Clinical Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2009 - 2014
  • Stay CONNECTed: Retaining HIV Positive Patients in Medical Care  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2009 - 2013
  • Viremia Copy-Years: Measuring the Effect of Cumulative HIV Burden on Outcomes  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2010 - 2013
  • RCT of an Augmented Test, Treat, Link, & Retain Model for NC and Texas Prisoners  awarded by University of North Carolina at Chapel Hill 2010 - 2013
  • Adherence to HIV Care: Advancing the Science  awarded by National Institute of Mental Health/NIH/DHHS 2007 - 2013
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2010 - 2012
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2011 - 2012
  • Investigator On

  • Geographic Variability in Time from HIV Diagnosis to Viral Suppression in the Deep South: A Roadmap to Accelerated Treatment Initiation  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2018 - 2023
  • Effectiveness of a Smoking Cessation Algorithm Integrated into HIV Primary Care  awarded by National Institute on Drug Abuse/NIH/DHHS 2018 - 2023
  • Private Grant  awarded by GlaxoSmithKline 2014 - 2022
  • Increasing Uptake of PrEP in Urban and Rural Black Women in the South  awarded by Johnson (Robert Wood) Foundation 2018 - 2021
  • Unsolicited R24 CFAR Network of Clinical Systems (CNICS)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2021
  • 3/3 Alcohol Research Consortium in HIV - Intervention Research Arm (ARCH-IRA)  awarded by National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS 2016 - 2021
  • Increasing Uptake of HIV Pre-Exposure Prophylaxis among Young, Black MSM in the South  awarded by National Institute of Mental Health/NIH/DHHS 2017 - 2021
  • Enhancing Information, Motivation, and Behavioral Skills to Promote Antihypertensive Medication Adherence Among Persons Living with HIV  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015 - 2020
  • Alabama Coalition for Testing, Interventions and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2017 - 2019
  • CITY Health II - The Center for the Study of Community Health  awarded by National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS 2014 - 2019
  • CITY Health II - The Center for the Study of Community Health - Research Core  awarded by National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS 2014 - 2019
  • DETECT-HIV - Discovering Emerging Trends Through Enhanced Community Testing For HIV Infection  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2018 - 2019
  • A Novel Neurorehabilitation Approach for Cognitive Aging with HIV  awarded by National Institute on Aging/NIH/DHHS 2015 - 2019
  • (COMPLETED VIA CIP) UAB Center for AIDS Research - UAB CFAR-Community Deep South Treatment Cascade Integration and Enhancement  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • UAB Center for AIDS Research - Administrative Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • UAB Center for AIDS Research - UAB CFAR- Administrative Supplement-Clinical Core Equipment  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by GlaxoSmithKline 2012 - 2019
  • Private Grant  awarded by Gilead Sciences 2014 - 2018
  • Managing Health Outcomes by Interventions in Literacy and Effectiveness  awarded by Johnson (Robert Wood) Foundation 2014 - 2018
  • ATN Coordinating Center  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2011 - 2018
  • Expanded Human Immunodeficiency (HIV) Testing for Disproportionately Affected Populations  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2017
  • Development of a Behavioral Intervention for Chronic Pain in Individuals with HIV  awarded by National Institute of Mental Health/NIH/DHHS 2014 - 2017
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2015 - 2017
  • Private Grant  awarded by ABBVIE INC 2013 - 2017
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2017
  • Private Grant  awarded by Gilead Sciences 2013 - 2017
  • Private Grant  awarded by Gilead Sciences 2013 - 2017
  • Expanded Human Immunodeficiency (HIV) Testing for Disproportionately Affected Populations  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2016
  • A Simulation Model for Understanding Prevention and Treatment of Depression Among HIV+Women  awarded by NSF - National Science Foundation 2012 - 2016
  • Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2011 - 2016
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2015 - 2016
  • Private Grant  awarded by Gilead Sciences 2013 - 2016
  • Birmingham Access to Care  awarded by AIDS United 2013 - 2016
  • Private Grant  awarded by Gilead Sciences 2013 - 2016
  • Expanded Human Immunodeficiency (HIV) Testing for Disproportionately Affected Populations  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2015
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2013 - 2015
  • Patient Reported Outcomes in Routine Clinical Care of Patients Infected with HIV  awarded by University of Washington, Seattle 2009 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2014 - 2015
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2010 - 2015
  • Private Grant  awarded by ABBVIE INC 2013 - 2014
  • Alabama Public Health Training Center (AL PHTC)  awarded by Health Resources and Services Administration/DHHS 2011 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2011 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2009 - 2014
  • UAB Center for AIDS Research - Community Deep South Treatment Cascade Integration and Enhancement  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2009 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2010 - 2014
  • Private Grant  awarded by Gilead Sciences 2010 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Alabama - Clinical Trials Unit  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2007 - 2013
  • Private Grant  awarded by Gilead Sciences 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • A Simulation Model for Understanding Prevention and Treatment of Depression Among HIV+Women  awarded by NSF - National Science Foundation 2012 - 2013
  • Education And Training

  • Bachelor of Science or Mathematics in Pre-Medicine / Pre-Medical Studies, University of Notre Dame
  • Doctor of Medicine, Vanderbilt University
  • Master of Science in Miscellaneous Biological Specializations, Duke University
  • UAB Hospital, Residency 2003
  • Duke University Medical Center, Postdoctoral Fellowship 2006
  • Full Name

  • Michael Mugavero
  • Blazerid

  • mugavero